CKD

MRA / finerenone safety

Spironolactone, eplerenone, finerenone (FIDELIO/FIGARO).

MRAfinerenonedrug safety

Required inputs

  • Serum K (mEq/L)
  • eGFR (mL/min/1.73 m²)
  • Agent

Equation or source

KDIGO 2024; FIDELIO-DKD NEJM 2020;383:2219.

Provenance and release status

Equation / algorithm
Spironolactone, eplerenone, finerenone (FIDELIO/FIGARO).
Formula version
mra-2024-v1
Tool version
2.4.0
Clinical risk class
C. HIGH-RISK CLINICAL CALCULATOR
Release status
Temporarily unavailable
Source status
Direct primary source identifier not yet resolved
Clinical review status
Clinical verification incomplete; active calculation unavailable
Clinical review date
Clinical review date not yet documented

DOI / PMID / direct guideline identifier not yet documented.

Assumptions

  • Entered values and units are accurate and apply to the population described by the cited source.
  • The published equation or rule is being used without a patient-specific clinical adjustment.

Important limitations

  • The result is a calculated estimate, not a prescription, treatment order, or diagnosis.
  • Local protocols, the full clinical context, and the primary source must be checked before use.
View verification status